| 000 | 01528 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515121311.0 | ||
| 264 | 0 | _c20081006 | |
| 008 | 200810s 0 0 eng d | ||
| 022 | _a1744-7682 | ||
| 024 | 7 |
_a10.1517/14712598.8.6.759 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Siao-Yi | |
| 245 | 0 | 0 |
_aComplement and cellular cytotoxicity in antibody therapy of cancer. _h[electronic resource] |
| 260 |
_bExpert opinion on biological therapy _cJun 2008 |
||
| 300 |
_a759-68 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntibodies, Neoplasm _xtherapeutic use |
| 650 | 0 | 4 | _aAntibody-Dependent Cell Cytotoxicity |
| 650 | 0 | 4 |
_aCD55 Antigens _xdrug effects |
| 650 | 0 | 4 |
_aCD59 Antigens _xdrug effects |
| 650 | 0 | 4 | _aComplement Pathway, Classical |
| 650 | 0 | 4 | _aCytotoxicity, Immunologic |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Isotypes _ximmunology |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aMembrane Cofactor Protein _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeoplasms _ximmunology |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aWeiner, George | |
| 773 | 0 |
_tExpert opinion on biological therapy _gvol. 8 _gno. 6 _gp. 759-68 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14712598.8.6.759 _zAvailable from publisher's website |
| 999 |
_c17971650 _d17971650 |
||